Press Releases
5.17.22
Civetta Therapeutics Appoints Jesse Smith, Ph.D. as CSO and Susan Ashwell, Ph.D. as SVP of Chemistry
READ MORE
9.2.21
Civetta Therapeutics Announces the Appointment of Christopher D. Roberts, Ph.D., as CEO
READ MORE
12.4.19
Civetta Therapeutics Announces $53 million Series A to Advance Lead Programs and Develop Proprietary Platform Targeting Propeller Proteins
READ MORE
